Clinical Trials Logo
  1. Home
  2. Intestinal Diseases
  3. NCT04340089
  4. Details
NCT04340089 Clinical Trial

Squatting on the Toilet and Capsule Endoscopy

Intestinal Diseases Clinical Trial

— SC  

Official title:
The Effect of Squatting on the Toilet on Gastric Transit Time and Complete Examination Rate of Capsule Endoscopy

Clinical Trial Details — Status: Enrolling by invitation

Administrative data
NCT number NCT04340089
Other study ID # wuzhixuan2003
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date April 15, 2020
Est. completion date March 31, 2022

Study information
Verified date April 2020
Source The Second Affiliated Hospital of Chongqing Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluates the effect of squatting on the toilet on gastric transit time and complete examination rate of capsule endoscopy.In the observation group, the patients could go to squatting on the toilet at any time as they want to after taking the capsule.

Description:

The subjects were divided into a control group and an observation group according to whether the patient squatted in the toilet, In the control group, the patients took discontinuous right lateral position, walked on a flat road and climbed the stairs alternately. In the observation group, in addition to the above ways, the patients could go to squatting on the toilet at any time in the first hour after taking the capsule. The operator observed the position of capsule every one hour. The examination was over when capsule endoscopy entered the colon. If the capsule remained in the small intestine, the examination continued until the capsule ran out of power.

Recruitment information / eligibility
Status Enrolling by invitation
Enrollment 300
Est. completion date March 31, 2022
Est. primary completion date September 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 75 Years
Eligibility Inclusion Criteria:

- unexplained gastrointestinal bleeding, unexplained chronic abdominal pain and diarrhea, suspected Crohn's disease, suspected small intestinal tumor, and patients needing to exclude small intestinal diseases.

Exclusion Criteria:

- suspected intestinal obstruction and intestinal stenosis, esophageal stenosis or dysphagia, history of abdominal operation, or diabetes mellitus.

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• squatting on the toilet
the patients could go to squatting on the toilet at any time as they want to after taking the capsule

Locations
Country Name City State
China The second affiliated hospital of Chongqing Medical University Chongqing Chongqing

Sponsors (1)
Lead Sponsor Collaborator
The Second Affiliated Hospital of Chongqing Medical University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary CER complete examination rate 72 hours
Secondary GTT gastric transit time 72 hours
See also
  Status Clinical Trial Phase
Completed NCT03032861 - The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones? N/A
Recruiting NCT02295254 - Microbiome Changes in Travelers to Tropical Destinations N/A
Completed NCT02246647 - Biomarkers for Intestinal Permeability in Patients With Constipation
Recruiting NCT05322486 - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Active, not recruiting NCT01037049 - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks Phase 2
Completed NCT01872286 - Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2 N/A
Completed NCT04080843 - Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients Phase 2
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Completed NCT02445365 - Remote Ischemic Conditioning in Patients With Ulcerative Colitis N/A
Recruiting NCT04949282 - Spanish Series of Patients Treated With the Radionuclide Lutetium177
Active, not recruiting NCT01995942 - Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial
Completed NCT02647866 - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Phase 2
Completed NCT02693782 - Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS) N/A
Not yet recruiting NCT02806206 - Prucalopride Prior to Small Bowel Capsule Endoscopy Phase 4
Completed NCT02831556 - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Terminated NCT04102163 - Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment
Terminated NCT02550860 - Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function Phase 3
Recruiting NCT02044952 - Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission Phase 2/Phase 3
Completed NCT02227602 - Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease N/A
Active, not recruiting NCT01028898 - Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome N/A